ALPS Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $403K | Buy |
5,152
+62
| +1% | +$4.85K | ﹤0.01% | 755 |
|
2025
Q1 | $369K | Buy |
+5,090
| New | +$369K | ﹤0.01% | 667 |
|
2024
Q1 | – | Sell |
-4,211
| Closed | -$321K | – | 1007 |
|
2023
Q4 | $321K | Sell |
4,211
-293
| -7% | -$22.3K | ﹤0.01% | 820 |
|
2023
Q3 | $312K | Buy |
4,504
+234
| +5% | +$16.2K | ﹤0.01% | 856 |
|
2023
Q2 | $403K | Buy |
4,270
+30
| +0.7% | +$2.83K | ﹤0.01% | 659 |
|
2023
Q1 | $351K | Buy |
+4,240
| New | +$351K | ﹤0.01% | 679 |
|
2022
Q3 | – | Sell |
-3,248
| Closed | -$309K | – | 1102 |
|
2022
Q2 | $309K | Sell |
3,248
-34
| -1% | -$3.24K | ﹤0.01% | 776 |
|
2022
Q1 | $386K | Buy |
3,282
+240
| +8% | +$28.2K | ﹤0.01% | 504 |
|
2021
Q4 | $394K | Buy |
3,042
+37
| +1% | +$4.79K | ﹤0.01% | 681 |
|
2021
Q3 | $340K | Sell |
3,005
-1,169
| -28% | -$132K | ﹤0.01% | 793 |
|
2021
Q2 | $432K | Hold |
4,174
| – | – | ﹤0.01% | 548 |
|
2021
Q1 | $349K | Buy |
+4,174
| New | +$349K | ﹤0.01% | 587 |
|
2020
Q3 | – | Sell |
-3,446
| Closed | -$238K | – | 860 |
|
2020
Q2 | $238K | Sell |
3,446
-379
| -10% | -$26.2K | ﹤0.01% | 688 |
|
2020
Q1 | $240K | Sell |
3,825
-957
| -20% | -$60K | ﹤0.01% | 607 |
|
2019
Q4 | $372K | Sell |
4,782
-207
| -4% | -$16.1K | ﹤0.01% | 646 |
|
2019
Q3 | $366K | Sell |
4,989
-14,124
| -74% | -$1.04M | ﹤0.01% | 579 |
|
2019
Q2 | $1.18M | Sell |
19,113
-2,304
| -11% | -$142K | 0.01% | 294 |
|
2019
Q1 | $1.37M | Sell |
21,417
-1,326
| -6% | -$84.6K | 0.01% | 269 |
|
2018
Q4 | $1.16M | Buy |
22,743
+33
| +0.1% | +$1.69K | 0.01% | 277 |
|
2018
Q3 | $1.32M | Buy |
+22,710
| New | +$1.32M | 0.01% | 312 |
|
2018
Q1 | – | Sell |
-12,312
| Closed | -$463K | – | 913 |
|
2017
Q4 | $463K | Hold |
12,312
| – | – | ﹤0.01% | 621 |
|
2017
Q3 | $449K | Sell |
12,312
-2,994
| -20% | -$109K | ﹤0.01% | 667 |
|
2017
Q2 | $603K | Buy |
15,306
+42
| +0.3% | +$1.66K | ﹤0.01% | 358 |
|
2017
Q1 | $479K | Buy |
15,264
+4,593
| +43% | +$144K | ﹤0.01% | 524 |
|
2016
Q4 | $333K | Sell |
10,671
-195
| -2% | -$6.09K | ﹤0.01% | 659 |
|
2016
Q3 | $437K | Sell |
10,866
-2,964
| -21% | -$119K | ﹤0.01% | 373 |
|
2016
Q2 | $460K | Sell |
13,830
-1,008
| -7% | -$33.5K | ﹤0.01% | 314 |
|
2016
Q1 | $436K | Buy |
+14,838
| New | +$436K | ﹤0.01% | 454 |
|
2015
Q3 | – | Sell |
-21,390
| Closed | -$508K | – | 699 |
|
2015
Q2 | $508K | Buy |
21,390
+336
| +2% | +$7.98K | ﹤0.01% | 489 |
|
2015
Q1 | $500K | Sell |
21,054
-9,564
| -31% | -$227K | ﹤0.01% | 574 |
|
2014
Q4 | $650K | Sell |
30,618
-4,104
| -12% | -$87.1K | 0.01% | 216 |
|
2014
Q3 | $591K | Sell |
34,722
-13,650
| -28% | -$232K | ﹤0.01% | 317 |
|
2014
Q2 | $692K | Buy |
48,372
+1,248
| +3% | +$17.9K | 0.01% | 213 |
|
2014
Q1 | $583K | Buy |
47,124
+5,592
| +13% | +$69.2K | 0.01% | 346 |
|
2013
Q4 | $451K | Buy |
41,532
+20,160
| +94% | +$219K | ﹤0.01% | 478 |
|
2013
Q3 | $248K | Buy |
+21,372
| New | +$248K | ﹤0.01% | 467 |
|